Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest update is out from Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( (AU:RMD) ).
ResMed Inc has reported a change in beneficial ownership, with Peter C. Farrell, a director and significant shareholder, disposing of 2,000 shares of common stock at a price of $251.47 per share. This transaction, conducted under a pre-established Rule 10b5-1 plan, reflects ongoing adjustments in the company’s shareholder structure, potentially impacting investor perceptions and market dynamics.
The most recent analyst rating on (AU:RMD) stock is a Buy with a A$45.00 price target. To see the full list of analyst forecasts on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh stock, see the AU:RMD Stock Forecast page.
More about Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
ResMed Inc operates in the healthcare industry, focusing on the development and manufacturing of products for the treatment of sleep disorders, particularly sleep apnea. The company is known for its innovative medical devices and cloud-connected solutions that improve patient outcomes and enhance the quality of life for individuals with respiratory conditions.
Average Trading Volume: 1,247,531
Technical Sentiment Signal: Buy
Current Market Cap: A$55.41B
Learn more about RMD stock on TipRanks’ Stock Analysis page.